B6.Cg-Tbcetm2c(EUCOMM)Hmgu/Ieg

Status

Available to order

EMMA IDEM:13235
International strain nameB6.Cg-Tbcetm2c(EUCOMM)Hmgu/Ieg
Alternative nameTBCEtm2c (TBCEfl/fl)
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolTbcetm2c(EUCOMM)Hmgu
Gene/Transgene symbolTbce

Information from provider

ProviderPhilip Wenzel
Provider affiliationCardiology 1, Center for Thrombosis and Hemostasis Mainz
Additional ownerTBCEtm2c founder mouse: C57BL/6N-Tbce/Ieg imported from Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt (GmbH) Ingolstaedter Landstr. 1 85764 Neuherberg
Genetic informationConditional knock-out of tubulin-folding cofactor E (Tbce) was achieved by using the “flip knockout first approach” (EUCOMM strategy): C57BL/6N-Tbcetm2a(EUCOMM)Hmgu/Ieg mice (EMMA strain EM:08306; https://www.infrafrontier.eu/search?keyword=Tbce) were crossed to flp recombinase-deleter mice. A subset of offspring carrying the tm2c allele (Tbce fl/wt) was outcrossed to wild-type C57BL/6N mice and floxed heterozygotes, negative for flp-deleter, were then chosen for brother × sister matings and subsequent line maintenance (Tbce fl/fl).
Phenotypic informationHomozygous:
Tissue-specific Tbce knock-out in cre recombinase-expressing tissue can be achieved by crossing Tbce tm2c (Tbce fl/fl) to a cre recombinase-expressing mouse.

Heterozygous:
Tissue-specific Tbce knock-out in cre recombinase-expressing tissue can be achieved by crossing Tbce tm2c (Tbce fl/fl) to a cre recombinase-expressing mouse..
Breeding history8 generations of sibmatings have been performed on C57BL/6 background.
References
  • Tubulin-folding cofactor E deficiency promotes vascular dysfunction by increased endoplasmic reticulum stress.;Efentakis Panagiotis, Molitor Michael, Kossmann Sabine, Bochenek Magdalena L, Wild Johannes, Lagrange Jeremy, Finger Stefanie, Jung Rebecca, Karbach Susanne, Schäfer Katrin, Schulz Andreas, Wild Philipp, Münzel Thomas, Wenzel Philip, ;2022;European heart journal;43;488-500; 34132336
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivinghomozygous C57BL/6N

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

Literature references

  • Tubulin-folding cofactor E deficiency promotes vascular dysfunction by increased endoplasmic reticulum stress.;Efentakis Panagiotis, Molitor Michael, Kossmann Sabine, Bochenek Magdalena L, Wild Johannes, Lagrange Jeremy, Finger Stefanie, Jung Rebecca, Karbach Susanne, Schäfer Katrin, Schulz Andreas, Wild Philipp, Münzel Thomas, Wenzel Philip, ;2022;European heart journal;43;488-500; 34132336

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).